Capital Bank & Trust CO Vertex Pharmaceuticals Inc Transaction History

Capital Bank & Trust CO

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $16.3 Million - $18.2 Million	-89,680 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$187.49 - $221.1 $193,677 - $228,396	1,033 Added 1.17%	89,680 $18.1 Million
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $355,246 - $414,087	1,716 Added 1.97%	88,647 $19 Million
Q4 2020 Feb 16, 2021	SELL	$207.01 - $276.09 $7.24 Million - $9.65 Million	-34,969 Reduced 28.69%	86,931 $20.5 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $284,794 - $337,653	1,114 Added 0.92%	121,900 $33.2 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $74,408 - $97,614	330 Added 0.27%	120,786 $35.1 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $2.33 Million - $2.9 Million	11,685 Added 10.74%	120,456 $28.7 Million
Q4 2019 Feb 18, 2020	BUY	$166.71 - $223.91 $18.1 Million - $24.3 Million	108,521 Added 43408.4%	108,771 $23.8 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $2,992 - $3,367	-18 Reduced 6.72%	250 $42,000
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $1,152 - $1,332	7 Added 2.68%	268 $49,000
Q1 2019 May 15, 2019	SELL	$163.73 - $194.7 $17,682 - $21,027	-108 Reduced 29.27%	261 $48,000
Q4 2018 Feb 14, 2019	BUY	$151.91 - $192.21 $30,837 - $39,018	203 Added 122.29%	369 $61,000
Q3 2018 Nov 14, 2018	BUY	$167.73 - $192.74 $19,288 - $22,165	115 Added 225.49%	166 $32,000
Q4 2017 Feb 14, 2018	BUY	$137.28 - $155.55 $7,001 - $7,933	51	51 $8,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $120B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Capital Bank & Trust CO, based on Form 13F filings with the SEC.

Stay updated on Capital Bank & Trust CO with notifications on news.